Michael Kauffman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Newton, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John Alden, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael Kauffman

Form 4 holding President of Development, Director

Verastem, Inc.

Security class
Common Stock
Shares / value
8,666
Estimated value
$86,660
Report date
21 Nov 2025
Price
$10.00
Ownership
Direct
Form 4 holding Director

Adicet Bio, Inc.

Security class
Common Stock
Shares / value
5,900
Estimated value
$8,437
Report date
05 Jun 2024
Price
$1.43
Ownership
Direct
Form 4 holding President of Development, Director

Verastem, Inc.

Security class
Stock Option (right to buy)
Shares / value
200,000
Estimated value
Report date
06 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Karyopharm Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
27,000
Estimated value
Report date
28 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Adicet Bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
26,400
Estimated value
Report date
21 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

KYNTRA BIO, INC.

Security class
Stock Option (Right to Buy)
Shares / value
7,000
Estimated value
Report date
12 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Michael Kauffman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .